drugset / Trial / NCT02279823
A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
RandomizedParallel-groupTriple-blindTreatment
Summary
In this proof-of-concept study, the safety and efficacy of a solution formulation will be investigated in male subjects with androgenetic alopecia (AGA) after twice daily application for up to 26 weeks.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-12
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clascoterone | Small molecule | 5 % | Topical |
| Comparator | Minoxidil | Small molecule | 5 % | Topical |